창상관리 생물제제 시장(2025-2029년)

The global wound care biologic market is forecasted to grow by USD 701.3 mn during 2024-2029, accelerating at a CAGR of 5.5% during the forecast period. The report on the global wound care biologic market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of chronic diseases and aging population, technological advancements and product innovation, growing number of geriatric populations.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global wound care biologic market is segmented as below:

By Product

• Skin substitutes
• Cell based products
• Collagen based products
• Topical agents
• Others

By Application

• Ulcers
• Surgical and traumatic wounds
• Burns
• Others

By End-User

• Hospitals and clinics
• ASCs
• Burn centers and wound clinics
• Others

Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Italy
  • The Netherlands
  • Spain
• Asia
• Rest of World (ROW)
• Rest of World (ROW)

This study identifies the rise of combination therapies and bioactive dressings as one of the prime reasons driving the global wound care biologic market growth during the next few years. Also, shift in point of care to outpatient and home settings and increased consolidation through mergers and acquisitions will lead to sizable demand in the market.

The report on the global wound care biologic market covers the following areas:

• Global wound care biologic market sizing
• Global wound care biologic market forecast
• Global wound care biologic market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global wound care biologic market vendors that include Amnio Technology LLC, Aroa Biosurgery Ltd., Avita Medical Inc., B.Braun SE, Celularity Inc., Coloplast AS, ConvaTec Group Plc, Derma Sciences Inc., Integra LifeSciences Corp., Kerecis Ltd., Marine Polymer Technologies Inc., Medline Industries LP, MiMedx Group Inc., Molnlycke Health Care AB, Organogenesis Holdings Inc., Skye Biologics Holdings LLC, Smith and Nephew plc, Stryker Corp., Vericel Corp.. Also, the global wound care biologic market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Product
  • Executive Summary - Chart on Market Segmentation by Application
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2024
• 4.4 Market outlook: Forecast for 2024-2029

5 Historic Market Size

• 5.1 Global Wound Care Biologic Market 2019 - 2023
  • Historic Market Size - Data Table on Global Wound Care Biologic Market 2019 - 2023 ($ million)
• 5.2 Product segment analysis 2019 - 2023
  • Historic Market Size - Product Segment 2019 - 2023 ($ million)
• 5.3 Application segment analysis 2019 - 2023
  • Historic Market Size - Application Segment 2019 - 2023 ($ million)
• 5.4 End-user segment analysis 2019 - 2023
  • Historic Market Size - End-user Segment 2019 - 2023 ($ million)
• 5.5 Geography segment analysis 2019 - 2023
  • Historic Market Size - Geography Segment 2019 - 2023 ($ million)
• 5.6 Country segment analysis 2019 - 2023
  • Historic Market Size - Country Segment 2019 - 2023 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI in the global wound care biologic market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2024 and 2029
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2024 and 2029
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2024 and 2029
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2024 and 2029
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2024 and 2029
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2024 and 2029
• 7.7 Market condition

8 Market Segmentation by Product

• 8.1 Market segments
• 8.2 Comparison by Product
• 8.3 Skin substitutes - Market size and forecast 2024-2029
• 8.4 Cell based products - Market size and forecast 2024-2029
• 8.5 Collagen based products - Market size and forecast 2024-2029
• 8.6 Topical agents - Market size and forecast 2024-2029
• 8.7 Others - Market size and forecast 2024-2029
• 8.8 Market opportunity by Product
  • Market opportunity by Product ($ million)

9 Market Segmentation by Application

• 9.1 Market segments
• 9.2 Comparison by Application
• 9.3 Ulcers - Market size and forecast 2024-2029
• 9.4 Surgical and traumatic wounds - Market size and forecast 2024-2029
• 9.5 Burns - Market size and forecast 2024-2029
• 9.6 Others - Market size and forecast 2024-2029
• 9.7 Market opportunity by Application
  • Market opportunity by Application ($ million)

10 Market Segmentation by End-user

• 10.1 Market segments
• 10.2 Comparison by End-user
• 10.3 Hospitals and clinics - Market size and forecast 2024-2029
• 10.4 ASCs - Market size and forecast 2024-2029
• 10.5 Burn centers and wound clinics - Market size and forecast 2024-2029
• 10.6 Others - Market size and forecast 2024-2029
• 10.7 Market opportunity by End-user
  • Market opportunity by End-user ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 North America - Market size and forecast 2024-2029
  • 12.3.1 US - Market size and forecast 2024-2029
  • 12.3.2 Canada - Market size and forecast 2024-2029
  • 12.3.3 Mexico - Market size and forecast 2024-2029
• 12.4 Europe - Market size and forecast 2024-2029
  • 12.4.1 Germany - Market size and forecast 2024-2029
  • 12.4.2 UK - Market size and forecast 2024-2029
  • 12.4.3 France - Market size and forecast 2024-2029
  • 12.4.4 Russia - Market size and forecast 2024-2029
  • 12.4.5 Italy - Market size and forecast 2024-2029
  • 12.4.6 The Netherlands - Market size and forecast 2024-2029
  • 12.4.7 Spain - Market size and forecast 2024-2029
• 12.5 Asia - Market size and forecast 2024-2029
  • 12.5.1 China - Market size and forecast 2024-2029
  • 12.5.2 Japan - Market size and forecast 2024-2029
  • 12.5.3 India - Market size and forecast 2024-2029
  • 12.5.4 South Korea - Market size and forecast 2024-2029
  • 12.5.5 Singapore - Market size and forecast 2024-2029
  • 12.5.6 Indonesia - Market size and forecast 2024-2029
  • 12.5.7 Thailand - Market size and forecast 2024-2029
• 12.6 Rest of World (ROW) - Market size and forecast 2024-2029
  • 12.6.1 Brazil - Market size and forecast 2024-2029
  • 12.6.2 Saudi Arabia - Market size and forecast 2024-2029
  • 12.6.3 UAE - Market size and forecast 2024-2029
  • 12.6.4 Australia - Market size and forecast 2024-2029
  • 12.6.5 South Africa - Market size and forecast 2024-2029
  • 12.6.6 Turkey - Market size and forecast 2024-2029
• 12.7 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Increasing prevalence of chronic diseases and aging population
  • Technological advancements and product innovation
  • Growing number of geriatric populations
• 13.2 Market challenges
  • High cost and inconsistent reimbursement frameworks
  • Stringent and evolving regulatory hurdles in market
  • Competition from traditional wound care and deficient clinician awareness
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2024 and 2029
• 13.4 Market opportunities
  • Rise of combination therapies and bioactive dressings
  • Shift in point of care to outpatient and home settings
  • Increased consolidation through mergers and acquisitions

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 Amnio Technology LLC
  • Amnio Technology LLC - Overview
  • Amnio Technology LLC - Product / Service
  • Amnio Technology LLC - Key offerings
  • SWOT
• 15.5 Aroa Biosurgery Ltd.
  • Aroa Biosurgery Ltd. - Overview
  • Aroa Biosurgery Ltd. - Product / Service
  • Aroa Biosurgery Ltd. - Key offerings
  • SWOT
• 15.6 Avita Medical Inc.
  • Avita Medical Inc. - Overview
  • Avita Medical Inc. - Product / Service
  • Avita Medical Inc. - Key offerings
  • SWOT
• 15.7 B.Braun SE
  • B.Braun SE - Overview
  • B.Braun SE - Product / Service
  • B.Braun SE - Key news
  • B.Braun SE - Key offerings
  • SWOT
• 15.8 Coloplast AS
  • Coloplast AS - Overview
  • Coloplast AS - Business segments
  • Coloplast AS - Key news
  • Coloplast AS - Key offerings
  • Coloplast AS - Segment focus
  • SWOT
• 15.9 Integra LifeSciences Corp.
  • Integra LifeSciences Corp. - Overview
  • Integra LifeSciences Corp. - Business segments
  • Integra LifeSciences Corp. - Key news
  • Integra LifeSciences Corp. - Key offerings
  • Integra LifeSciences Corp. - Segment focus
  • SWOT
• 15.10 Kerecis Ltd.
  • Kerecis Ltd. - Overview
  • Kerecis Ltd. - Product / Service
  • Kerecis Ltd. - Key offerings
  • SWOT
• 15.11 Marine Polymer Technologies Inc.
  • Marine Polymer Technologies Inc. - Overview
  • Marine Polymer Technologies Inc. - Product / Service
  • Marine Polymer Technologies Inc. - Key offerings
  • SWOT
• 15.12 Medline Industries LP
  • Medline Industries LP - Overview
  • Medline Industries LP - Product / Service
  • Medline Industries LP - Key offerings
  • SWOT
• 15.13 MiMedx Group Inc.
  • MiMedx Group Inc. - Overview
  • MiMedx Group Inc. - Business segments
  • MiMedx Group Inc. - Key offerings
  • MiMedx Group Inc. - Segment focus
  • SWOT
• 15.14 Molnlycke Health Care AB
  • Molnlycke Health Care AB - Overview
  • Molnlycke Health Care AB - Product / Service
  • Molnlycke Health Care AB - Key offerings
  • SWOT
• 15.15 Organogenesis Holdings Inc.
  • Organogenesis Holdings Inc. - Overview
  • Organogenesis Holdings Inc. - Product / Service
  • Organogenesis Holdings Inc. - Key offerings
  • SWOT
• 15.16 Smith and Nephew plc
  • Smith and Nephew plc - Overview
  • Smith and Nephew plc - Business segments
  • Smith and Nephew plc - Key news
  • Smith and Nephew plc - Key offerings
  • Smith and Nephew plc - Segment focus
  • SWOT
• 15.17 Stryker Corp.
  • Stryker Corp. - Overview
  • Stryker Corp. - Business segments
  • Stryker Corp. - Key news
  • Stryker Corp. - Key offerings
  • Stryker Corp. - Segment focus
  • SWOT
• 15.18 Vericel Corp.
  • Vericel Corp. - Overview
  • Vericel Corp. - Product / Service
  • Vericel Corp. - Key offerings
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations